Sigyn Therapeutics Files 10-Q for Q1 2025
Ticker: SIGY · Form: 10-Q · Filed: May 20, 2025 · CIK: 1642159
| Field | Detail |
|---|---|
| Company | Sigyn Therapeutics, Inc. (SIGY) |
| Form Type | 10-Q |
| Filed Date | May 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-filing, company-information
TL;DR
Sigyn Therapeutics (formerly Reign Sapphire) filed its Q1 2025 10-Q. Check financials.
AI Summary
Sigyn Therapeutics, Inc. filed a 10-Q for the period ending March 31, 2025. The company, formerly known as Reign Resources Corp and Reign Sapphire Corp, is incorporated in Delaware and operates in the Surgical & Medical Instruments & Apparatus sector. Its business address is in Beverly Hills, California.
Why It Matters
This filing provides investors with an update on Sigyn Therapeutics' financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing with no immediate red flags or significant new information presented in the provided snippet.
Key Players & Entities
- Sigyn Therapeutics, Inc. (company) — Filer of the 10-Q
- Reign Resources Corp (company) — Former company name
- Reign Sapphire Corp (company) — Former company name
- 20250331 (date) — End of reporting period
- 20250520 (date) — Filing date
- BEVERLY HILLS, CA (location) — Business and mailing address
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is for the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 20, 2025.
What were Sigyn Therapeutics' former company names?
Sigyn Therapeutics was formerly known as Reign Resources Corp and Reign Sapphire Corp.
In which state was Sigyn Therapeutics incorporated?
Sigyn Therapeutics, Inc. was incorporated in Delaware (DE).
What is Sigyn Therapeutics' business address?
Sigyn Therapeutics' business address is 9190 W Olympic Blvd # 263, Beverly Hills, CA 90212.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 20, 2025 regarding Sigyn Therapeutics, Inc. (SIGY).